2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $2.5B | $2.8B | $3B | $3.3B | $3.6B |
Cost of Revenue | $1.7B | $1.9B | $2.1B | $2.2B | $2.4B |
Gross Profit | $782M | $900M | $922M | $1.1B | $1.2B |
Gross Profit % | 32% | 33% | 31% | 34% | 34% |
R&D Expenses | $85M | $95M | $97M | $103M | $116M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $69M | $315M | $368M | $411M | $518M |
Dep. & Amort. | $112M | $113M | $107M | $109M | $137M |
Def. Tax | -$44M | $116M | $2.9M | -$28M | $0 |
Stock Comp. | $13M | $17M | $18M | $20M | $26M |
Chg. in WC | $51M | -$92M | -$221M | -$12M | -$82M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $860M | $648M | $561M | $489M | $439M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $860M | $648M | $561M | $489M | $439M |
Receivables | $527M | $576M | $655M | $701M | $737M |
Inventory | $361M | $431M | $534M | $575M | $591M |
ITT achieved strong financial performance in 2024, with 11% revenue growth (7% organic), 12% EPS growth, and $440 million in free cash flow, despite challenges like the Wolverine divestiture and higher interest expenses.
The company expanded its operating margin by 80 basis points to nearly 18%, driven by favorable price-cost actions, productivity improvements, and strong volume growth across all segments.
ITT completed strategic portfolio transformations, including the acquisitions of Zbanioy and Qesaria, which contributed significantly to growth, and the divestiture of Wolverine. The acquisitions are expected to drive further growth in 2025.
For 2025, ITT projects organic revenue growth of 3%-5%, with a total revenue target of over $3.7 billion. EPS is expected to grow by 8% at the midpoint, with a free cash flow target of approximately $475 million.
The company anticipates continued margin expansion in 2025, with a 90 basis point increase to 18.6% at the midpoint, supported by strong backlog conversion, productivity gains, and contributions from recent acquisitions.